This startup wants to prove gene-editing embryos is safe for making healthy babies

Origin Genomics’ mission to make healthy, gene-edited babies Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.

Cathy Tie, the founder and CEO of Origin Genomics, replenishes nutrients sustaining cells the New York City startup is using to test its technology for repairing defective genes.

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics . "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located in New York City. Tie, CEO of Origin, asked NPR to withhold the exact location for security reasons.

Once inside, Tie snaps on a pair of blue rubber gloves and points to a gray metal tank on the floor that looks like a giant thermos.

"This is a cryogenic storage unit that has liquid nitrogen inside, which is where our embryos are stored," she says.

Tie twists open the black lid, letting wisps of white fog from the liquid nitrogen swirl out from the tank. Tie gently slides out a long metal rod cradling frosted glass tubes at the end.

"So as you can see, there's four tubes in here," Tie says. "Each tube can contain up to 10 embryos."

Copyright for this text belongs to NPR.